Clinical significance of perineural invasion by prostate cancer

Published Date: 08 Mar 2023

This study examines the clinical impact of unilateral perineural invasion in prostate cancer. How does unilaterality affect long-term oncology outcomes?

Read Full News

Latest News

A 2-Year-Old Girl With a Single Pink “Bump” on Her Abdomen

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, rapid growth, or preceding trauma.

Rules for Thee, Not for Me: Neuroscience & Double Standards

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.


Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, rapid growth, or preceding trauma.

With respect to the so-called ‘moral compass’, humans invariably judge others more harshly than they judge themselves.

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

News All Time

Preventing Burnout in Clinical Practice

Perfectionism, empathy, and blurred boundaries — together with workload, staff shortages, and constant connectivity — create a high risk for stress for clinicians.

Death Rates Higher With ‘Alternative’ Cancer Therapies

Complementary and alternative medicine is more popular than ever, but does it help or hinder conventional cancer treatment?

S2 Episode 5: HER2 Low Testing in the ADC Era

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

HF With Improved Ejection Fraction

Heart Failure with Improved ejection fraction is characterized by previously reduced left ventricular ejection fraction (≤40%) that subsequently improves to >40%. This review highlight existing clinical gaps and proposes future research directions to refine risk stratification and therapeutic approaches for this evolving HF population.

S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagnostics.

Radiofrequency Ablation: A First-Line Treatment Option

Drs Kaniksha Desai and Iram Hussain discuss the use of radiofrequency ablation for the treatment of hyperthyroidism.

S2 Episode 5: DNA Repair and Replication Stress in Endometrial Cancer

Drs Ursula A. Matulonis and Joyce F. Liu discuss targeting DNA damage and repair and replication stress in endometrial cancer.

May 09 2025 This Week in Cardiology

The controversial KETO-CTA study, tough decisions in subclinical AF, and another potentially huge benefit for GLP-1 agonist drugs are discussed by John Mandrola, MD, in this week’s podcast.

Should All Newborns Be Screened for Congenital Hypothyroidism?

Drs Kaniksha Desai and Larry Fox discuss congenital hypothyroidism, including when to test and how to treat it.

S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

USCAP 2025

Read clinically focused news coverage of key developments from USCAP 2025

S3 Episode 3: The 2025 updates of the American Diabetes Association

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.

Episode 1: Lupus by the Numbers: What the Data Reveals

Join Drs Maureen McMahon and Peter Izmirly as they discuss lupus epidemiology, and why knowing the data is especially important for physicians on the frontlines of healthcare.

Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum

Join Drs Maureen McMahon and Brad Rovin as they discuss the KDIGO, ACR and EULAR guidelines as they relate to lupus nephritis.

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach

Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis.

Recommended News For You

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

a brand-new generic therapy for different types of cancer.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

Severe obesity associated with reduced prevalence of recommended cancer screenings

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

New study elucidates obesity's role in fueling breast cancer progression

Year in Review: Chronic Lymphocytic Leukemia

Recommended Articles For You

Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life 

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction  

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition 

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.

2.

Smart exercise planning could boost recovery for people with cancer

3.

Updates from the 2022 WHO classification of kidney epithelial tumors

4.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

5.

After two years, a significant left nasal obstruction was finally diagnosed.

1.

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction

2.

Gut microbiota in curing cancer

3.

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients

4.

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection

5.

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

4.

Navigating the Complexities of Ph Negative ALL - Part I

5.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot